Is it time to invest in biotech?

With advancements in biotechnology and the potential for breakthroughs in areas such as gene editing and personalized medicine, many investors are asking, 'Is it time to invest in biotech?' The sector has seen significant growth in recent years, driven by promising research and a growing global population with increasing healthcare needs. However, investing in biotech also comes with risks, including lengthy and expensive drug development processes and the potential for clinical trial failures. So, the question remains: is the potential for high returns worth the risks associated with investing in this dynamic and rapidly evolving industry?